Early Mechanisms of Chemoresistance in Retinoblastoma

SIMPLE SUMMARY: Despite advances in chemotherapy for retinoblastoma over the past three decades, chemoresistance remains a major source of ocular and systemic morbidity. Here, we studied the early molecular mechanisms leading to carboplatin resistance. Carboplatin is one of the most widely used agen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Michelle G., Kuznetsoff, Jeffim N., Owens, Dawn A., Gallo, Ryan A., Kalahasty, Karthik, Cruz, Anthony M., Kurtenbach, Stefan, Correa, Zelia M., Pelaez, Daniel, Harbour, J. William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563111/
https://www.ncbi.nlm.nih.gov/pubmed/36230889
http://dx.doi.org/10.3390/cancers14194966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563111/
https://www.ncbi.nlm.nih.gov/pubmed/36230889
http://dx.doi.org/10.3390/cancers14194966

Ejemplares similares